Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • jesse.livermore jesse.livermore Oct 11, 2012 7:45 AM Flag

    Anatomy of a Biotech Sale....

    Akanz and Epi...

    Thnx for the support...

    Gary, When I mention six months off, I'm considering a few months sales to get a grip on how the medical community is warming up to Vascepa, not the launch date,which should occur in Q1 2013.

    Right now I do not see a sale in the next few months being a good idea for either the buyer or the seller. Although this company is a biotech, it more closely resembles a retailer and its value is going to be tied to revenue generation. Once the drug hits the market both parties will have a better idea of the company's value...which right now would just be a guess for either side.

    Epi..Re the Quiet period....Have no information why this anomaly is taking place...Could be they are in discussion with a partner for marketing and sales with an eye to the future development of a combined statin-EPA drug....Doubt it's NCE related, or a buyout...

    ": ) JL

    Sentiment: Strong Buy

 
AMRN
2.79-0.20(-6.69%)Aug 30 4:00 PMEDT